MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 561.00
+9.50 (1.72%)
Nov 4, 2026, 5:29 PM CET
MedCap AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,321 | 2,108 | 1,807 | 1,587 | 1,111 | 916.3 |
Other Revenue | 53.6 | 1.6 | 0.6 | 1.6 | 0.2 | - |
| 2,374 | 2,110 | 1,807 | 1,589 | 1,112 | 916.3 | |
Revenue Growth | 18.59% | 16.73% | 13.74% | 42.96% | 21.30% | 11.80% |
Cost of Revenue | 937.4 | 871.9 | 749.6 | 660.7 | 446.8 | 357.7 |
Gross Profit | 1,437 | 1,238 | 1,058 | 928.3 | 664.7 | 558.6 |
Selling, General & Admin | 854.9 | 791.5 | 698.5 | 601.1 | 443.5 | 384.6 |
Other Operating Expenses | 7.9 | 4.2 | 3 | 7.9 | -9.2 | -5.3 |
Operating Expenses | 1,050 | 949 | 816.9 | 712.1 | 515.6 | 454.8 |
Operating Income | 386.9 | 288.7 | 240.8 | 216.2 | 149.1 | 103.8 |
Interest Expense | -64 | -31.5 | -18.5 | -15.6 | -16.4 | -9.4 |
Interest & Investment Income | 2.8 | 5.1 | 8.3 | 7 | 2.3 | 0.4 |
Earnings From Equity Investments | - | - | - | - | - | 1.3 |
Currency Exchange Gain (Loss) | 17.4 | 17.4 | 5 | 14.7 | 2.8 | 1.7 |
Other Non Operating Income (Expenses) | -0.3 | -0.1 | 0.2 | 0.1 | 0.1 | - |
EBT Excluding Unusual Items | 342.8 | 279.6 | 235.8 | 222.4 | 137.9 | 97.8 |
Gain (Loss) on Sale of Assets | - | - | - | - | 20 | 4 |
Asset Writedown | - | - | - | -0.9 | -6.5 | - |
Other Unusual Items | 9.4 | 9.4 | 25.7 | - | 0.6 | 15.1 |
Pretax Income | 352.2 | 289 | 261.6 | 222.3 | 152 | 117 |
Income Tax Expense | 77.4 | 68.3 | 52.3 | 49.8 | 34 | 18.9 |
Earnings From Continuing Operations | 274.8 | 220.7 | 209.3 | 172.5 | 118 | 98.1 |
Net Income to Company | 274.8 | 220.7 | 209.3 | 172.5 | 118 | 98.1 |
Minority Interest in Earnings | -0.6 | -0.9 | -1.9 | -0.3 | -0.4 | -1.6 |
Net Income | 274.2 | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 |
Net Income to Common | 274.2 | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 |
Net Income Growth | 39.26% | 5.98% | 20.44% | 46.43% | 21.87% | 58.46% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change | 0.22% | 0.94% | 0.05% | 0.33% | 0.04% | 3.10% |
EPS (Basic) | 18.30 | 14.67 | 14.00 | 11.63 | 7.94 | 6.52 |
EPS (Diluted) | 18.30 | 14.67 | 14.00 | 11.60 | 7.90 | 6.50 |
EPS Growth | 39.02% | 4.80% | 20.66% | 46.84% | 21.54% | 53.18% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 396.9 | 317 | 318.2 | 205.9 | 59.2 | 71 |
Free Cash Flow Per Share | 26.49 | 21.13 | 21.41 | 13.86 | 4.00 | 4.80 |
Gross Margin | 60.52% | 58.67% | 58.52% | 58.42% | 59.80% | 60.96% |
Operating Margin | 16.30% | 13.69% | 13.32% | 13.61% | 13.41% | 11.33% |
Profit Margin | 11.55% | 10.42% | 11.48% | 10.84% | 10.58% | 10.53% |
Free Cash Flow Margin | 16.72% | 15.03% | 17.61% | 12.96% | 5.33% | 7.75% |
EBITDA | 509.2 | 377.2 | 304.8 | 268.3 | 188.6 | 141.1 |
EBITDA Margin | 21.45% | 17.88% | 16.86% | 16.89% | 16.97% | 15.40% |
D&A For EBITDA | 122.3 | 88.5 | 64 | 52.1 | 39.5 | 37.3 |
EBIT | 386.9 | 288.7 | 240.8 | 216.2 | 149.1 | 103.8 |
EBIT Margin | 16.30% | 13.69% | 13.32% | 13.61% | 13.41% | 11.33% |
Effective Tax Rate | 21.98% | 23.63% | 19.99% | 22.40% | 22.37% | 16.15% |
Revenue as Reported | 264.6 | - | - | - | - | - |